August 2024

The pharmacological management of type 2 diabetes has changed dramatically over the past 20 years, with medications now chosen based on patient characteristics and comorbidities, as well as the PBS indications.

Obesity is a complex, multifactorial chronic disease that contributes directly to cardiovascular disease risk factors, including type 2 diabetes, hypertension and dyslipidaemia. Weight loss and maintenance have been shown to improve associated risk factors and reduce cardiovascular mortality.

People presenting with both depression and diabetes are more likely to have complications from both conditions, have more challenges with managing these and require more support and understanding to overcome these difficulties. This article presents a framework for holistic assessment and management in affected patients.

Osteoporosis is an important cause of morbidity and mortality in women with increasing age. Despite the wide availability of treatments, there are significant gaps in care, which need to be bridged by identifying women at high risk of fracture and starting treatment earlier.